You are currently visiting the Safic-Alcan France website.
LIFEINU™ LRGG 350
Provided by Gnosis By Lesaffre
About
LifeinU® L. Rhamnosus GG is a bacterial probiotic ingredient for nutraceutical applications, supplying Lactobacillus rhamnosus GG (registered under ATCC 53103), one of the most extensively studied probiotic bacterial strains worldwide, first isolated in 1983 and backed by over 25 years of documented use.
Key Benefits:
• Robust strain with proven ability to survive harsh gastrointestinal conditions, including gastric acid and intestinal transit
• Positioned across multiple health domains: gut health (occurrence and duration of antibiotic- or infection-related diarrhea, abdominal discomfort management), immune and respiratory wellness (seasonal respiratory support), and oral health (dental care positioning)
• Family-oriented positioning, suitable for both children (from 3 years old) and adults
• High-concentration production: 350 x 10⁹ CFU/g, manufactured in Europe under a proprietary production process
• Enhanced stability: 24 months at 4°C, supporting reliable shelf performance under refrigerated conditions
• Recommended dosage: 1 x 10⁹ to 2 x 10¹⁰ CFU/day for children (>3 years) and adults
• Sustainable sourcing through biotransformation, reducing raw material consumption
• Halal, Kosher, Non-GMO, Vegan, Lactose-free and Gluten-free, suitable for all diets
• Not recommended for individuals in fragile health conditions (severely immunocompromised individuals[HJ3.1][TU3.2][HJ3.3]), consistent with standard probiotic precautions
• Produced by Gnosis by Lesaffre and distributed by Safic-Alcan
Typical Applications:
Lactobacillus rhamnosus GG / probiotic bacteria strain for gut health, immune support, and family nutrition formulations, including children’s health ranges. Suitable for capsules, sachets, and powder blends requiring refrigerated storage. Complementary ingredient for synbiotic and multi-strain combination formulas alongside probiotic yeasts such as ibSium® or Lynside® Pro SCB and prebiotic ingredients such as Lynside® Prebiotic Yeast.
| Benefits |
|
|---|---|
| Applications |
|
| Category |
|
| Certifications |
|
| Origin Nature |
|
About gnosis by lesaffre
For over 30 years, Lesaffre has been involved in Human Health & Nutrition as part of its ambition to Better Nourish and Protect the Planet. In November 2018, Lesaffre acquired Gnosis Advanced Biotech and officially combined it with Lesaffre Human Care to form a new Business Unit named Gnosis by Lesaffre. At Gnosis by Lesaffre, we are committed to cultivating and to delivering nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and wellbeing, thanks to the power of microorganisms and biotransformation processes like fermentation. Put differently, we explore life to improve living. Our vision: At Gnosis by Lesaffre, we strive for a world that moves better, digests better, ages better, feels better, and, ultimately, lives better thanks to microorganisms and biotransformation.
Probiotic Bacterium for Gut, Immune and Family Health
LifeinU® L. Rhamnosus GG 350 is a probiotic bacterial ingredient supplying Lactobacillus rhamnosus GG, registered in the ATCC collection under the number 53103. First isolated in 1983, it is one of the most extensively documented probiotic strains in the scientific literature, with over 800 scientific studies and more than 200 clinical trials supporting its use across multiple areas of health.
As a robust bacterial strain, L. rhamnosus GG is able to survive harsh gastrointestinal conditions, including gastric acid and intestinal transit, without requiring additional protective technology. Its documented areas of benefit span gut health (reduction in occurrence and duration of diarrhoea linked to antibiotics or gastrointestinal infections, alleviation of abdominal pain in children with irritable bowel symptoms), immune and respiratory health (reduced incidence of common respiratory infections), and oral health (support for dental caries prevention), making it a strain suited to formulations addressing the whole family, from children above 3 years old to adults.
LifeinU® L. Rhamnosus GG 350 is produced in Europe to a high, market-standard concentration of 350 x 10⁹ CFU/g, through a proprietary production process delivering robust stability over time, and is manufactured using biotransformation, one of the most sustainable approaches for reducing raw material consumption. It is Halal, Kosher, Non-GMO, Vegan, lactose-free and gluten-free, suitable for all diets, with a recommended dosage ranging from 1 x 10⁹ to 2 x 10¹⁰ CFU/day.
Falling within the Probiotics category, LifeinU® L. Rhamnosus GG 350 is positioned as a science-backed, single-strain bacterial ingredient for manufacturers developing gut health, immune support, and family nutrition nutraceutical formulations.